Wilson Sonsini’s Biotech Summit 2025

Wednesday, October 22 & Thursday October 23

The Newbury Boston
One Newbury Street, Boston, MA 02116

Wilson Sonsini’s 2nd Annual Biotech Summit will address topics of critical importance to Biotech and Biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI trends in healthcare, and developments in M&A. This unique event will bring together leaders from across the biotech industry, including esteemed researchers, policymakers, prominent investors, and CEOs.

Wednesday, October 22

6:00 – 9:00 p.m. Opening Reception and Dinner

Thursday, October 23

7:30 a.m. – 9:00 a.m. Registration and Networking Breakfast
8:00 a.m. – 5:00 p.m. Partnering Hall
9:00 a.m. – 6:00 p.m. Panel Discussions and Networking
6:20 p.m. – 8:30 p.m. Venture Capital Uncorked: Wine Tasting Closing Reception

The Newbury Boston
One Newbury Street, Boston, MA 02116

Conference Fee: $350

Accommodations:

We have contracted guest rooms at discounted pricing at The Newbury Boston. Your conference preferential hotel room rate is $519 and is guaranteed on a first come, first served basis until Monday, September 22, 2025.

For room reservations, call The Newbury Boston at (617) 536-5700 and reference the “Wilson Sonsini Biotech Summit 2025” or click here for an online reservation.

Cancellations:

Cancellations can be processed online using your confirmation number before Wednesday, October 8. After this point, refund requests must be made to Alison Cornfeldt at acornfeldt@wsgr.com.

We cannot guarantee that a refund will be issued after the cancellation deadline.

Agenda Topics Include:

  • Alternative Financings
  • Chinese Biotech
  • European Big Pharma
  • Venture Capital Financing Trends
  • AI and Life Sciences
  • Patent Strategies for Successful Biotech-Pharma
  • Trends and Strategies for Navigating the Current Market
  • Navigating Perspectives in Deal-Making
  • CEOs Shaping the Future of Healthcare

Partnering Hall

Connect with innovative Biotech start-ups from around the globe through the Partnering Hall, which provides personalized opportunities for investors and large Pharma companies to meet with start-ups that are searching for and pursuing potential investment, partnering, and acquisition opportunities.

BioTech 2024 Recap

Wilson Sonsini’s inaugural Biotech Summit convened diverse and influential leaders from across the biotech industry, including esteemed researchers, policymakers, prominent investors, and CEOs. The Biotech Summit, attended by over 250 participants, was structured around a single-track program comprising of 10 insightful sessions. More than 30 industry leaders contributed to these sessions as panelists and speakers, leading key industry topics including venture capital trends, antitrust issues, and FDA insights.